共 24 条
- [2] Alp aslan, 2004, Mikrobiyoloji Bulteni, V38, P77
- [3] Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 877 - 889
- [7] Chudy M., 2013, WHO/BS/2013.2227
- [10] Kang SH, 2012, ANN CLIN LAB SCI, V42, P370